The Warnings Page: Permax, Risperdal, Forteo, Vinarol, Ketek

Risk of Cardiac Valvulopathy
Added to Permax Warnings

Health Canada, the country's equivalent of the FDA, and Eli Lilly recently issued a letter to health care professionals stating that the package insert accompanying Permax will be expanded to include additional information regarding the drug's association with cardiac valvulopathy.

According to the April 14 letter, post-marketing surveillance recently found that a small number of patients experienced symptoms or manifestations of valvulopathy involving the aortic, mitral and tricuspid valves while using the treatment for Parkinson's disease.

The post-marketing reports stated that in some patients, these experiences subsided upon cessation of the …